Board of Trustees
Kimo Stine, MD
Kimo Stine graduated from the University of Kansas and completed his pediatric residency at the Kansas University Medical Center in Kansas City, Kansas. He completed his training in Pediatric Hematology Oncology at Duke University. He moved to Little Rock, Arkansas after spending 2 years at Tulane University in New Orleans. Dr. Stine’s focus upon arriving at Arkansas Children’s Hospital in 1991 was potential new therapies for pediatric malignancies in particular bone tumors and Acute Myeloid Leukemia and the role of Biologic Response Modifiers. Shortly after arriving at Arkansas Children’s Hospital, Dr. Stine began to care for several children with Langerhans Cell Histiocytosis. Many of these children had recurrent disease or were not responding to their current regimen. Dr. Stine became interested in utilizing new therapies for these patients and soon began to study the effect of 2-Chlorodeoxyadenosine (2-CDA). This work and work he had done in the Pediatric Oncology Group led to his acquaintance and soon active involvement in the Histiocyte Society and the Histiocytosis Association. Dr. Stine is currently Professor of Pediatrics at the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital. He is also the program director for the Pediatric Hematology Oncology Fellowship program and Medical Director for the Arkansas Center for Bleeding Disorders.
Dr. Stine joined the Histiocytosis Association Board of Trustees in July of 2014 and is looking forward to getting more involved with the organization.